SCHEMBL24089914

SCHEMBL24089914

CCCCC[C@H](NC(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](CCC(=O)O)NC(=O)C(NC(=O)CCOCCOCCOCCOCCOCCNC(=O)CCCC[C@@H]1CC[C@H]2NC(=O)N[C@@H]12)[C@@H](C)O)C(C)C)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NC(C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)O)[C@H](C)O

nearest known ligand 0.51

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ RAMP3 O60896 2/20 0.51
▸ CALCR P30988 2/20 0.51
▸ TFPI P10646 5/20 0.50
▸ KDM1A O60341 1/20 0.49
▸ MAOB P27338 1/20 0.49
▸ KDM5A P29375 1/20 0.49
▸ KDM1B Q8NB78 1/20 0.49
▸ CXCR4 P61073 2/20 0.48
▸ NPY2R P49146 8/20 0.47
▸ NPY4R P50391 7/20 0.47
▸ NPY5R Q15761 7/20 0.47
▸ NPY1R P25929 5/20 0.47
▸ GLP1R P43220 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22550646 0.89 RAMP3 (0.53) RAMP3CALCRKDM1AMAOBKDM5A
SCHEMBL24089913 0.78 GLP1R (0.46) GLP1R
SCHEMBL24089915 0.77 GLP1R (0.51) RAMP3CALCRTFPIGLP1R
SCHEMBL31540378 0.75 CALCR (0.54) RAMP3CALCRTFPINPY2RNPY4R
SCHEMBL30966632 0.75 NPY2R (0.59) CALCRTFPINPY2RNPY4RNPY5R
SCHEMBL22550671 0.74 RAMP3 (0.53) RAMP3CALCRKDM1AMAOBKDM5A
SCHEMBL22550672 0.74 GLP1R (0.54) RAMP3CALCRTFPIGLP1R
SCHEMBL30974385 0.73 CALCRL (0.59) NPY2RNPY4RNPY5RNPY1R
SCHEMBL30974423 0.73 NTSR1 (0.58) NPY2RNPY4RNPY5RNPY1R
SCHEMBL30335912 0.72 NPY2R (0.60) TFPIKDM1AMAOBKDM5AKDM1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210380640-A1 SARS-CoV-2 EPITOPE-TARGETED PEPTIDE IMMUNOSTIMULANTS INSTITUTE FOR SYSTEMS BIOLOGY 2021-12-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210380640-A1 SARS-CoV-2 EPITOPE-TARGETED PEPTIDE IMMUNOSTIMULANTS ACE2, CD14, ICOSLG RAMP3 2031/4885CALCR 549/4885TFPI 3476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback